Specialty Pharmacy

Share This Page

Specialty Pharmacy

Specialty pharmacy focuses on high cost, high touch medication therapy for patients with complex disease states. Medications in specialty pharmacy range from oral to cutting edge injectable and biologic products. The disease states treated range from cancer, multiple sclerosis and rheumatoid arthritis to rare genetic conditions.  

A specialty pharmacist may work in a variety of practice settings. Some pharmacists in this practice area work in pharmacies dedicated to only products that are considered specialty medications. In this setting, pharmacists may work in a variety of areas including dispensing, medication therapy management, patient advocacy and therapy compliance. Some pharmacists work in institutional or health system settings and may be involved with the patients therapy from in-patient to ambulatory care sites. Other pharmacists work in more traditional retail settings and either focus on certain specialty disease states at their practice sites or work with an affiliated specialty pharmacy provider to dispense these complex medications.  

SPECIALTY COVERAGE
May 18, 2017
May 18, 2017
FDA expanded on Wednesday the approved use of ivacaftor (Kalydeco—Vertex Pharmaceuticals) for treating cystic fibrosis. The decision expands the...
FDA expanded on Wednesday the approved use of ivacaftor (Kalydeco—Vertex Pharmaceuticals) for treating cystic fibrosis. The decision expands the number of rare gene mutations that the drug can now treat from 10 mutations to 33.
MORE
May 09, 2017
May 09, 2017
PTC Therapeutics said Monday that it would receive a net price of $35,000 annually per patient for deflazacort (Emflaza), the muscular dystrophy...
PTC Therapeutics said Monday that it would receive a net price of $35,000 annually per patient for deflazacort (Emflaza), the muscular dystrophy drug it acquired from Marathon Pharmaceuticals in April.
MORE
May 08, 2017
May 08, 2017
FDA has approved edaravone (Radicava—Mitsubishi Tanabe Pharma America) for the treatment of patients with amyotrophic lateral sclerosis (ALS), also...
FDA has approved edaravone (Radicava—Mitsubishi Tanabe Pharma America) for the treatment of patients with amyotrophic lateral sclerosis (ALS), also referred to as Lou Gehrig's disease.
MORE